België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

gea farm technologies - jodium 5 mg/ml - tepeldip/tepelspray, oplossing - 5 mg/ml - jodium 5 mg/ml - disinfectants - rund; geit; schaap

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

gea farm technologies (uk) ltd. - jodium (moleculair) - tepeldip oplossing, tepelspray, oplossing - disinfectants

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

beijing tong ren tang pudu health centre b.v. amsterdamse veerkade 66 2512 aj den haag - pueraria lobata, radix, droog extract, ethanol-water (85-15), (7.8-8.5=1) 300 mg/stuk - filmomhulde tablet - briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lecithine (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; tartrazine (e 102) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd ; zonnegeel fcf (e 110), briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lecithine (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; tartrazine (e 102) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd ; zonnegeel fcf (e 110)

Europese Unie - Nederlands - EMA (European Medicines Agency)

biogen netherlands b.v. - dimethylfumaraat - multiple sclerose - immunosuppressiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europese Unie - Nederlands - EMA (European Medicines Agency)

biogen netherlands b.v. - peginterferon beta-1a - multiple sclerose - immunostimulants, - behandeling van relapsing-remitting multiple sclerose bij volwassen patiënten.

Europese Unie - Nederlands - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - multiple sclerose - selectieve immunosuppressiva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 en 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Europese Unie - Nederlands - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen natrium - spier-atrofie, spinale - andere medicijnen voor het zenuwstelsel - spinraza is geïndiceerd voor de behandeling van 5q spinal muscular atrophy.